Updated Jul 16, 2026
FRANCIS LAURA has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.98M.
Laura Francis is the Chief Executive Officer of SI-BONE, Inc., a medical device company specializing in minimally invasive surgical implant systems. She has held this position and has been involved in the company's growth and development within the medical device industry.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.2K | $14.73 | $47K |
| 2026-05-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.7K | $14.75 | $54K |
| 2026-05-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.0K | $14.57 | $29K |
| 2026-05-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.2K | $14.67 | $33K |
| 2026-05-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.9K | $14.75 | $57K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.0K | $15.30 | $31K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 7.9K | $15.44 | $122K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.2K | $15.29 | $34K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.2K | $15.31 | $49K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 39.8K | $15.29 | $608K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 18.9K | $15.32 | $289K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.9K | $15.29 | $60K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 15.6K | $15.35 | $239K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | A — Grant or award | 57.4K | $0.00 | |
| 2026-02-19 | SIBN | SI-BONE, Inc. | A — Grant or award | 57.4K | $0.00 | |
| 2026-02-19 | SIBN | SI-BONE, Inc. | A — Grant or award | 114.7K | $0.00 | |
| 2026-02-18 | BRKR | BRUKER CORP | A — Grant or award | 4.5K | $0.00 | |
| 2025-08-18 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.9K | $15.59 | $61K |
| 2025-08-18 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.2K | $15.59 | $50K |
| 2025-08-18 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.0K | $15.62 | $32K |
Laura Francis is the Chief Executive Officer of SI-BONE, Inc., a medical device company specializing in minimally invasive surgical implant systems. She has held this position and has been involved in the company's growth and development within the medical device industry.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 33 open-market sales ($2.98M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live FRANCIS LAURA profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.